LOGIN
Bisphosphonates in revision THA ineffective in altering pseudomembrane cytokine expression
July 2013
Bisphosphonates in revision THA ineffective in altering pseudomembrane cytokine expression
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Effect of alendronate on pseudomembrane cytokine expression in patients with aseptic osteolysis
J Arthroplasty. 2010 Sep;25(6):958-63Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
10 patients, scheduled for revision hip arthroplasty due to aseptic osteolysis, were randomized into two groups, one received the alendronate for 8 weeks prior to surgery and another received placebo. The pseudo membrane was harvested at the time of surgery and immunohistochemistry and various cytokine expressions were tested in the two groups. In conclusion, the alendronate therapy prior to revis...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.